I The pharmacological characteristics of adrenoceptors at different temperatures were assessed on the basis of the effects of various a-and /-adrenoceptor agonists and antagonists on electrically-driven left atria and spontaneously-beating pairs of atria from rats. 2 Phenoxybenzamine (Pbz) potentiated inotropic responses of left atria to noradrenaline (NA) at 31°C, produced significantly less potentiation at 24°C and inhibited responses at 17°C; it had little effect on responses to CaC12. Both Pbz and phentolamine inhibited responses to phenylephrine more effectively at 17 than at 31°C. N-cyclohexylmethyl-N-ethyl-/-chloroethylamine hydrochloride (GD-131), a haloalkylamine with negligible a-adrenoceptor blocking activity, caused only potentiation of responses to NA at 170C. 3 The presence of phentolamine during incubation with Pbz eliminated block of responses to NA and revealed a potentiation that was equivalent at all three temperatures tested. Phentolamine did not alter the block of responses to 5-hydroxytryptamine by Pbz. Protection of a-adrenoceptors by phentolamine during exposure to [3H1-Pbz significantly decreased the amount of label bound to the myocardium at 1 7°C, but did not alter binding at 3 1 OC. 4 Inhibition of responses to NA by propranolol decreased with temperature, and the magnitude of the change increased with the concentration of propranolol. Compared to 31 'C, the effect of the highest concentration of propranolol. (4.0 gM) was significantly decreased at 24°C, and the effects of all except the lowest concentration (0.04 ,uM) were significantly decreased at 1 70C. 5 The potency of isoprenaline decreased and that of phenylephrine increased at low temperatures, and their potency ratio was much lower at 17 than at 31 0C for both the inotropic and chronotropic responses of spontaneously-beating atria. However, the ratio was unaffected by temperature in electrically-driven left atria. A similar difference between spontaneously-beating and driven preparations is apparent in the data of other workers, but its basis is not clear. 6 Atria from rats pretreated with 6-hydroxydopamine (6-OHDA) were sensitized to the effects of NA, and there was no increase in a-adrenoceptor properties at low temperatures. Little aadrenoceptor activity could be demonstrated in chemically denervated atria at any temperature. 6-OHDA pretreatment did not alter the binding of [3H1-Pbz at 310C, but decreased it significantly at 17°C. Pretreatment with reserpine caused some sensitization, but did not significantly alter the characteristics of the adrenoceptors or their responses to temperature. 7 It is concluded that the adrenoceptors of rat atria are affected by temperature in much the same way as those of frog hearts, although the transition from /3-to a-adrenoceptor properties may begin at a slightly higher temperature. a-Adrenoceptor properties appear to require the presence of intact adrenergic nerves but not the presence of normal stores of neurotransmitter.
Introduction
Several studies have shown that the adrenoceptors retention of a-and P-adrenoceptor antagonists mediating inotropic and chronotropic responses of occurred sharply between 17 and 230C, and that frog hearts are /3 at higher and have a major a-alkylation of a-adrenoceptors by phenoxybenzamine component at lower temperatures (Kunos & at a low temperature prevented the appearance of /3- Szentivanyi, 1968; Buckley & Jordan, 1970; Kunos, adrenoceptors when the temperature was raised were
Yong & Nickerson, 1973b , Harri, 1973  Tirri, Harri interpreted to indicate that a-and /3-adrenoceptors & Laitinen, 1974) . The observations that reciprocal may be interconvertible forms of a single basic changes in the blocking effectiveness and the tissue structure (Kunos & Nickerson, 1976) . Recent studies have suggested that adrenoceptors of the mammalian myocardium are similarly affected by temperature (Kunos, Vermes-Kunos, Boyd & Nickerson, 1973a; Benfey, Kunos & Nickerson, 1974; Amer & Byrne, 1975) . The present observations on rat atria confirm the shift from /3-towards a-adrenoceptor properties at low temperatures, and indicate that the aadrenoceptor component in inotropic responses requires intact sympathetic innervation. An abstract of some of these findings has been published (Kunos et al., 1973a) .
Methods

Preparation of isolated atria and experimental design
Male Sprague-Dawley rats (180-300 g) were lightly anaesthetized with ether and the hearts quickly removed. Left atria or spontaneously-beating pairs of atria were isolated and mounted in 20 ml organ baths containing modified Krebs-Henseleit solution of the following composition (mM): NaCl 115.3, KCl 4.6, CaCI2 1.8, MgSO4 1.1, NaHCO3 22.1, KH2PO4 1.1 and glucose 1.1, (pH 7.43) bubbled with 5% CO2 and 95% 02. The temperature was controlled by a refrigerated, constant temperature circulating water bath (Lauda, Model K-2-R). Left atria were driven through small platinum electrodes by square-wave pulses of 3 ms duration at a voltage slightly above threshold (0.3-1.5 V) and a rate of 1 Hz (Grass stimulator, Model S88). Isometric contractions were recorded by force-displacement transducers (Grass, FT 83C) and a polygraph (Grass, Model 7). Rates of contraction were determined directly from the polygraph records.
The preparations were allowed to equilibrate for at least an hour at 31°C with frequent changes of the medium and the temperature was then set at 31, 24 or 170C. Each preparation was used at only one temperature. Agonists were added cumulatively and the maximal response was determined in every experiment. The basal contractile amplitude often decreased significantly after the first concentrationresponse curve was determined. In such cases, a second concentration-response curve to the same agonist was obtained and used as control. All responses are expressed as a percentage of the maximal control increase in force of contraction or rate. Absolute values for force of contraction are also indicated for most series of experiments. The basal contractile amplitude increased and the absolute change in force in response to inotropic drugs decreased with decreasing temperature. Some preparations were insensitive to all agonists at 17°C, and remained insensitive despite extensive washing and repeated challenges with agonist. These are not included in the calculations of mean responses. Pretreatment with 6-hydroxydopamine (6-OHDA) and reserpine Rats with an initial body weight of 80-100 g were pretreated with 6-OHDA according to the schedule proposed by Thoenen & Tranzer (1968) . Two doses of 50 mg/kg were given intravenously within 24 h, followed a week later by 2 x 100 mg/kg. Experiments on isolated left atria were performed one week after the last dose of 6-OHDA. This dose schedule has been shown to reduce the NA content of rat hearts by more than 90%, and the resulting supersensitivity is qualitatively the same as that after other forms of sympathetic denervation (Haeusler, Haefely & Thoenen, 1969 (Yong & Nickerson, 1973) . Other drugs used were phenoxybenzamine hydrochloride (Smith (1 70C). potentiated inotropic responses to noradrenaline (NA) at 31°C; concentration-response curves were shifted to the left (log dose-ratio -0.99 + 0.12), but the maximal developed tension was unaltered (Figure la) . A similar exposure to Pbz at 170C inhibited responses to NA; the change in the mean EC50 was not statistically significant, but the maximal response was significantly decreased (P <0.02) (Figure ic) . A concentration of 0.7 gM Pbz had similar but smaller effects. Although the effect of Pbz at 240C was similar to that at 310C, the shift to the left of the NA concentration-response curve was significantly smaller (log dose-ratio -0.53+0.10, P<0.02) and the maximal developed tension was slightly reduced (Figure lb) . Inotropic responses to phenylephrine were inhibited by Pbz at both 17 and 310C, but the block was significantly greater at the low than at the high temperature (Figure 2a pectedly, the maximal response to phenylephrine at 170C was significantly decreased. As observed in frog hearts, the Pbz blockade at 170C developed slowly during the washout period and 3x 10 8 3>t1-7 3x10-341 the first NA concentration-response curve often showed some potentiation. Blockade then developed gradually and was stable after 1 hour. Figure 3 shows that almost complete block of the inotropic response of a left atrial preparation to NA at 17°C was associated with only a slight decrease in the contractile response to CaC12. In three experiments at 17°C, atria were exposed for 40min to 10.4 IM GD-131, a haloalkylamine with negligible a-adrenoceptor blocking properties. This drug moderately potentiated inotropic responses to NA in all experiments.
Effects of phentolamnine on block by and binding of /3H1-phenoxvbenzamine in rat left atria Exposure in the presence of phentolamine (26.5 pM)
abolished the temperature dependence of the effects of Pbz (7.3 ,uM), and potentiation of response to NA at all three temperatures ( Figure 4 ) was similar to that produced by Pbz alone at 31 'C. This indicated that inhibition of responses to NA by Pbz at 17°C and the decrease in potentiation at 24°C were due to aadrenoceptor blockade and that the potentiating effect of Pbz is largely independent of temperature. In three experiments at 1 7°C, Pbz (7.3 pM) almost completely blocked inotropic responses to 5-hydroxytryptamine (5-HT), and this effect was unaltered by exposure in the presence of phentolamine (26.5 tM) in three other preparations.
In contrast to frog hearts (Kunos & Nickerson, 1976) , the radioactivity retained by rat atria exposed to PHI -Pbz was not significantly changed by temperature, and was even slightly higher at 31 'C than at the lower temperatures ( Figure 5 , open columns). However, protection against Pbz block by phentolamine at 17°C was associated with a for the inotropic effects of isoprenaline and phenylephrine were determined from control concentration-response curves of spontaneouslybeating pairs of atria and of electrically-driven left atria. pD2 values for chronotropic responses were also determined in the former preparations. Sensitivity to isoprenaline was significantly lower and that to phenylephrine significantly higher at 17 than at 310C for both the inotropic and chronotropic responses of spontaneously-beating preparations (Table 2 ). This resulted in a considerable decrease in the potency ratio of the two amines at the lower temperature. However, in electrically-driven left atria the inotropic potencies of both amines increased with decreasing temperature, and there was no change in the potency ratio.
Responses of left atria from rats pretreated with 6-hydroxydopamine
Haloalkylamines can inhibit the uptake of NA into adrenergic nerve endings (Iversen, Salt & Wilson, 1972) , which could contribute to the potentiation of myocardial responses to NA by these drugs. The receptor protection experiments presented above showed that the potentiating effect of Pbz is present at all temperatures, but is masked by its a-adrenoceptor blocking action at 170C. Therefore, destruction of sympathetic nerve endings by 6-OHDA might reduce (Figure 6a) . Unexpectedly, Pbz did not significantly alter the NA concentration-response curve of atria from pretreated animals at 170C. The blocking action observed in control preparations at this temperature was completely absent (Figure 6b ). Pbz blockade of responses to phenylephrine at both temperatures (see Figure 2 ) was also nearly abolished by 6-OHDA pretreatment.
The amount of radioactivity retained after exposure to [3HJ-Pbz (7.3 g M) at 310C was almost identical in atria from 6-OHDA pretreated and control animals ( Figure 7) . However, the absence of a-adrenoceptor blockade at 1 70C in the atria from 6-OHDA pretreated rats was associated with a significantly lower retention of label than that of control atria exposed at the same temperature. phentolamine (see Figure 5 ).
Pretreatment with 6-OHDA also abolished the decrease in the effect of propranolol noted when the temperature of control preparations was reduced. Cumulative doses of propranolol caused slightly greater shifts to the right of the NA concentrationresponse curves of 6-OHDA pretreated (Table 3) at 17 as at 310C, significantly greater for 0.4 gM, and was clearly greater for all concentrations than that produced in control atria at 170C. Thus, the inotropic effect of NA in atria from 6-OHDA pretreated rats appeared to be mediated only by P-adrenoceptors at both test temperatures.
Responses of left atria from rats pretreated with reserpine
The results with atria from 6-OHDA pretreated rats indicated that adrenergic innervation may be necessary for the shift from /3-to a-adrenoceptor properties in rat atria at low temperature. This effect of innervation might be due to the neurotransmitter or to some other influence of the nerves. A tentative differentiation of these possibilities was sought by testing atria from rats pretreated with reserpine to deplete endogenous NA. Reserpine pretreatment moderately increased sensitivity of left atria to both ., NA and phenylephrine, but did not alter the temperature-dependence of Pbz blockade (Figure 8 ). (Kunos & Szentivanyi, 1968; Buckley & Jordan, 1970; Kunos et al., 1973b; Harri, 1973; Kunos & Nickerson, 1976) . The observed changes in the effectiveness of drugs acting on a-and ,B-adrenoceptors can be interpreted to indicate an interconversion of /3-to a-adrenoceptors as the temperature of a mammalian heart preparation was lowered. In both frog and rat preparations the greatest change in adrenoceptor properties occurred below 24°C, but the upper limit of receptor transition appears to be somewhat higher in the mammalian heart. In the present experiments on rat atria there was an increase in the effect of a-and a decrease in the effect of P-adrenoceptor antagonists when the temperature was reduced from 31 to 240C. Pbz is known to react with nonspecific sites (Harvey & Nickerson, 1954) as well as with several receptors, and the change in its effectiveness with temperature has been attributed to the former (Benfey, 1975 (Harvey & Nickerson, 1953; Rosen & Ehrenpreis, 1972) . As expected from this change in chemical reactivity, we have observed that the nonspecific binding of [3H]-Pbz to frog heart homogenates increases progressively with incubation temperature, more than 10-fold over the range of 4 to 240C (Kunos & Nickerson, unpublished results). In contrast, the block of inotropic responses of rat atria was greater at low temperatures. (2) The change in block with temperature was essentially the same for the competitive antagonist phentolamine as it was for Pbz. (3) The presence of phentolamine during incubation with Pbz at 170C prevented block of responses to both NA and phenylephrine, but did not alter the potentiation of responses to NA at 310C. Prevention of the block by phentolamine strongly supports the involvement of specific a-adrenoceptors because the same concentration of this competitive aadrenoceptor antagonist had no effect on the block of responses to 5-HT by Pbz. (4) GD-13 1, a haloalkylamine that has been shown to lack significant a-adrenoceptor blocking activity in other preparations (Nickerson & Gump, 1949; Kalsner & Nickerson, 1969) , but which has a nonspecific reactivity comparable to Pbz (Harvey & Nickerson, 1954 CaCl2 . This indicated that the block was not due to the inhibition of calcium fluxes that can be produced by high concentrations of a haloalkylamine (see Triggle, 1972) . (6) Block by Pbz was largely eliminated by pretreatment with 6-OHDA. It is difficult to see how exposure to this drug one and two weeks prior to the experiment could alter nonspecific alkylation of the myocardium.
Observations on the tissue retention of [3H1-Pbz also indicate an increase in the number of aadrenoceptors at low temperatures. In contrast to our previous observations on frog hearts (Kunos & Nickerson, 1976) , the total retention of label was not increased at low temperatures. However, effective protection of a-adrenoceptors by phentolamine significantly reduced the binding of [3H]-Pbz at 17°C, whereas phentolamine had little effect on either binding of or potentiation by [3H1-Pbz at 310C. This indicated that, as in the frog heart, the binding of Pbz to a-adrenoceptors was increased at the low temperature to an identifiable fraction of the label. It is probable that failure to demonstrate a significant difference in the total radioactivity retained by rat atria at 31 and 17°C was due to greater nonspecific binding at the higher temperature. The reason for this difference in nonspecific binding in the two preparations is not clear, but it could be related to the fact that the experimental conditions (route of access of drugs, temperature) were more physiological for frog hearts than for rat atria. The presence of cut surfaces in rat left atria might also promote the type of temperature-dependent, nonspecific binding of Pbz that we have observed in frog heart homogenates (see above).
The results with antagonists provided the most clearcut evidence of changes in adrenoceptor characteristics. The effectiveness of both a competitive (phentolamine) and a nonequilibrium (Pbz) aadrenoceptor antagonist increased as the temperature was lowered, and there was a reciprocal change in the effect of the P-adrenoceptor antagonist propranol. aAdrenoceptor blockade did not reduce responses to NA and had only a small effect on those to phenylephrine at 31 0C, as would be expected from the many observations which indicate that inotropic responses of the mammalian myocardium at physiological temperatures are mediated predominantly by,-adrenoceptors (see Furchgott, 1970) . As in many other studies of a-adrenoceptor blockade in the heart (Wenzel & Su, 1966; Govier, 1968; Nakashima, Maeda, Sekiya & Hagino, 1971;  Schumann, Endoh & Wagner, 1974; Mugelli, Ledda & Mantelli, 1976) , we used somewhat higher (micromolar) concentrations of antagonists than are needed in most smooth muscle preparations. However, even among smooth muscle structures, aadrenoceptors can vary significantly (Sheys & Green, 1972) , and a considerable difference between smooth and cardiac muscle (Schumann et al., 1974) is not surprising. Although their contributions are difficult to assess, other characteristics of both the drugs and the tissue could also contribute to the apparent relative resistance to blockade. The significant P-adrenoceptor activity still present at 17°C could be important in 'masking' the degree of block produced by aadrenoceptor antagonists. Pronethalol has been reported to reveal an a-adrenoceptor component of the inotropic action of adrenaline and NA, but not of isoprenaline, at 32°C (Govier, 1968) , and the combination of pindolol and phentolamine produces a greater than additive block of responses to phenylephrine (Schiimann et al., 1974) . It is of interest that the concentration-response relation for propranolol is flatter at 17 than at 310C in control atria (Table 1) , but is much steeper at 170C in atria from 6-OHDA pretreated rats (Table 3) in which the response has little or no a-adrenoceptor component. Similarly, the slope for phentolamine block of responses to phenylephrine at 370C was very low, but was converted to that expected of a competitive antagonist by a low concentration of pindolol (Schumann et al., 1974) .
Occult potentiation could also reduce the apparent block of responses to NA by Pbz at 17°C; protection of a-adrenoceptors by phentolamine revealed a comparable potentiation at all temperatures. The interaction of blockade and potentiation is also apparent in the observation that the significant shift to the left of the NA concentration-response curve produced by Pbz at 31 IC was abolished in guinea-pig atria incubated with Pbz at 17°C and subsequently tested at the higher temperature (Benfey, 1975, Table 2 ). This observation also indicates that the block produced by Pbz at a low temperature persisted when the temperature was raised, as previously reported for frog hearts (Kunos et al., 1973b; Kunos & Nickerson, 1976) .
Irrespective of the mechanisms responsible for differences in the apparent sensitivity of different tissues to adrenoceptor blockade, dose or concentration per se does not establish or exclude the interaction of a drug with specific receptors. This must be assessed on the basis of the relative inhibition of responses to specific and nonspecific agonists, and in the case of nonequilibrium antagonists, particularly, by 'receptor protection' experiments (Furchgott, 1954) .
Although changes in the effects of sympathomimetic amines observed in the present study are compatible with the changes in adrenoceptor characteristics deduced from the effects of antagonists, some details are difficult to explain. The receptor specificity of adrenoceptor agonists is lower than that of antagonists, but the potency ratio of an agonist with predominantly /3-and one with relatively less /3-and more a-adrenoceptor activity would be expected to decrease as the temperature was lowered if there is a shift from /3 towards a in receptor characteristics. The potency ratios of isoprenaline and phenylephrine for both inotropic and chronotropic responses did decrease considerably with temperature when the drugs were tested on spontaneously-beating preparations, but there was no change in the ratio in electrically-driven rat atria. A similar failure to demonstrate temperature-induced changes in agonist ratios in electrically-driven frog ventricle strips was recently reported (Benfey, 1975) , but these results are difficult to compare with others because the preparations were much less sensitive to adrenaline and isoprenaline than are spontaneously-beating frog hearts (Erlij, Cetrangolo & Valadez, 1965; Kunos & Nickerson, 1976) .
Both low temperature and electrical stimulation can influence the potency of agonists by mechanisms other than changes in receptor characteristics, and a coincidence of these effects could mask a change in receptor properties. Changes in the balance of a-and ,B-adrenoceptors are readily demonstrated by agonist ratios when only one of these factors is involved, i.e. temperature in spontaneously-beating preparations (Buckley & Jordan, 1970; Broadley, 1972; Harri, 1973; Tirri et aL, 1974; Amer & Byrne, 1975) , or electrical driving at a high temperature in atria from rats with altered thyroid state (Nakashima et al., 197 1; Kunos et al., 1974) .
Factors other than changes in receptor characteristics that could affect agonist potency ratios include the release of endogenous NA by electrical stimulation (Jewell & Blinks, 1968) , and the effects of released transmitter could be augmented by reduced reuptake (Kirpekar & Wakade, 1968) and decreased catechol-O-methyltransferase (COMT) activity (Opperman, Ryan & Haavik, 1972; Munoz-Ramirez, Ryan & Buckner, 1975) at lower temperatures. Any change in COMT activity could also have a direct effect on the isoprenaline-phenylephrine potency ratio. Some involvement of released endogenous NA is suggested by our observation that reserpine pretreatment increased the apparent a-adrenoceptor characteristics of electrically-driven rat atria, but a full explanation of differences between the responses of electrically-driven and spontaneously-beating preparations to agonists must await further studies. The fact that shifts in receptor characteristics are more readily revealed by antagonists than by agonists could be due to some action of the former that would 'direct' unstable, transitional phase receptors into a specific configuration. There is no direct evidence for this mechanism at present, but it might provide an explanation for the unexpected reduction by phentolamine of maximal responses to phenylephrine. This was a consistent finding, but it cannot be explained on the basis of current receptor theory. Such an action of antagonists might also be the basis for the observations that very low concentrations of propranolol, present during incubation with Pbz and subsequently washed out, greatly increase the block produced by a standard exposure to Pbz in frog hearts at low temperature (Kunos & Nickerson, unpublished observations) , and decrease the threshold blocking concentration of Pbz in atria from hypothyroid rats (Kunos, 1977) Our experiments on atria from 6-OHDA pretreated rats revealed an unexpected effect of sympathetic innervation on receptor characteristics. In addition to supersensitivity to the inotropic effect of NA, atria from pretreated rats showed almost pure /3-adrenoceptor characteristics under all conditions tested. Pbz did not inhibit responses to NA at 17°C, and propranolol was even more effective at this temperature than at 310C. In addition, block of responses to phenylephrine by Pbz was markedly reduced at both temperatures, which indicated that even the small a-adrenoceptor component of responses at 310C was decreased by denervation. Similarly, denervation did not alter the binding of [3H]-Pbz at 310C, but significantly less label was retained by denervated than by control atria at 170C. These results all indicate that the a-adrenoceptor component of inotropic responses requires intact sympathetic innervation and that denervation 'stabilizes' adrenoceptors in the P configuration. A similar decreased effectiveness of a-adrenoceptor antagonists on chronically denervated cat nictitating membranes has been observed, and has been attributed to qualitative changes in the aadrenoceptors (Varma, 1966) or to other postsynaptic changes (Langer & Trendelenburg, 1968) .
Depletion of the NA content of rat atria by reserpine pretreatment produced moderate supersensitivity, but did not prevent the changes in adrenoceptor properties induced by temperature.
Indeed, Pbz blocked responses to NA at 170C even more effectively than it did in control atria. These observations suggest that adrenergic innervation may affect adrenoceptor characteristics by a mechanism independent of the presence of neurotransmitter. The nature of this effect is unknown, but passage of neuroplasmic constituents other than acetylcholine across the myoneural junction has been shown in skeletal muscle (Korr, Wilkinson & Chornock, 1967) , and the possibility that such substances are involved in various 'neurotrophic' phenomena has been considered (Guth, 1968) .
The shift in the properties of myocardial adrenoceptors from /3 towards a after thyroidectomy was also prevented by 6-OHDA but not by reserpine pretreatment (Kunos & Mucci, 1975) . This further illustrates the role of sympathetic innervation in determining adrenoceptor characteristics and the similarity of temperature-and hormone-induced adrenoceptor interconversions.
Few details of metabolic changes that may accompany denervation are known, but it appears not unreasonable to suggest that denervation supersensitivity may be associated with an increase in some component of tissue metabolism. If this is so, the observed effects of chemical denervation would fit into the general pattern relating adrenoceptor properties to tissue metabolism that is emerging from other studies. In addition to low temperature, metabolic inhibitors (Nickerson & Nomaguchi, 1950; Kunos & Szentivanyi, 1968; Matheny & Ahlquist, 1975) , thyroid deficiency (Nakashima et al., 1971; ) and a reduced rate of contraction of ventricular muscle (Endoh & Schiimann, 1975; Mugelli et al., 1976) appear to promote aadrenoceptor properties and, conversely, muscle activity augments ,B-adrenoceptor characteristics (Szentivanyi, Kunos & Juhasz-Nagy, 1970) . /3-Adrenoceptors are generally more sensitive than a to noradrenaline (t,) and adrenaline, and this interconversion may serve to adapt the mechanical response of a tissue to its metabolic state.
